“If being quiet, priority for drug review might get pushed back”

The Pharmaceutical Benefits Division at the Ministry of Health and Welfare emphasized importance of participation of pharmaceutical companies for the ‘Annual Review Plan’ prepared this year.

Since they are making general plans to last a year, there is a high chance for the priority to be pushed backwards if leaving no opinion.

Myung-Sup Kwak, Pharmaceutical Benefits Division Manager, stressed...